Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 6/20 | 0.51 |
| ▸ | CDC25B | P30305 | 5/20 | 0.51 |
| ▸ | ACP1 | P24666 | 4/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | PRKCA | P17252 | 1/20 | 0.43 |
| ▸ | CES2 | O00748 | 3/20 | 0.39 |
| ▸ | CES1 | P23141 | 3/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7239635 | 1.00 | PTPN1 (0.51) | PTPN1CDC25BACP1LMNAKDM4E | |
| SCHEMBL3789174 | 1.00 | PTPN1 (0.51) | PTPN1CDC25BACP1LMNAKDM4E | |
| SCHEMBL7243740 | 0.98 | PTPN1 (0.49) | PTPN1CDC25BACP1LMNAKDM4E | |
| SCHEMBL20826897 | 0.93 | KDM4E (0.50) | PTPN1CDC25BACP1LMNAKDM4E | |
| SCHEMBL7995598 | 0.86 | HSD17B10 (0.52) | PTPN1CDC25BACP1LMNAKDM4E | |
| SCHEMBL23281434 | 0.85 | ALDH1A1 (0.44) | PTPN1CDC25BACP1LMNAKDM4E | |
| SCHEMBL31440186 | 0.81 | KDM4E (0.42) | PTPN1CDC25BACP1LMNAKDM4E | |
| SCHEMBL7238832 | 0.81 | ALDH1A1 (0.42) | PTPN1CDC25BACP1LMNAKDM4E | |
| SCHEMBL31603 | 0.80 | BACE1 (0.44) | PTPN1CDC25BACP1LMNAKDM4E | |
| SCHEMBL19126937 | 0.79 | EPHX2 (0.39) | PTPN1CDC25BACP1LMNAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2965758-B1 | OSTEOPONTIN PRODUCTION INHIBITOR COMPRISING DICTYOPYRONE DERIVATIVE OR DIHYDRODICTYOPYRONE DERIVATIVE AS ACTIVE INGREDIENT | UNIV TOHOKU (JP) | 2018-01-03 | — | — | EP | disclosed |
| US-9463188-B2 | Osteopontin production inhibitor containing dictyopyrone derivative or dihydrodictyopyrone derivative as active ingredient | TOHOKU UNIVERSITY (JP) | 2016-10-11 | — | — | US | disclosed |
| EP-2965758-A1 | OSTEOPONTIN PRODUCTION INHIBITOR COMPRISING DICTYOPYRONE DERIVATIVE OR DIHYDRODICTYOPYRONE DERIVATIVE AS ACTIVE INGREDIENT | Tohoku University (JP) | 2016-01-13 | — | — | EP | disclosed |
| CN-105209038-A | Osteopontin production inhibitor comprising dictyopyrone derivative or dihydrodictyopyrone derivative as active ingredient | UNIV TOHOKU NAT UNIV CORP | 2015-12-30 | — | — | CN | disclosed |
| US-20150366851-A1 | OSTEOPONTIN PRODUCTION INHIBITOR CONTAINING DICTYOPYRONE DERIVATIVE OR DIHYDRODICTYOPYRONE DERIVATIVE AS ACTIVE INGREDIENT | TOHOKU UNIVERSITY (JP) | 2015-12-24 | — | — | US | disclosed |
| WO-2014136161-A1 | OSTEOPONTIN PRODUCTION INHIBITOR COMPRISING DICTYOPYRONE DERIVATIVE OR DIHYDRODICTYOPYRONE DERIVATIVE AS ACTIVE INGREDIENT | 国立大学法人東北大学 (JP) | 2014-09-12 | — | — | WO | disclosed |
| US-8436210-B2 | Amide compound and bacterial disease control agent for agricultural and horticultural use | THE UNIVERSITY OF TOKYO (JP) | 2013-05-07 | — | — | US | disclosed |
| US-20100261920-A1 | AMIDE COMPOUND AND BACTERIAL DISEASE CONTROL AGENT FOR AGRICULTURAL AND HORTICULTURAL USE | THE UNIVERSITY OF TOKYO (JP) | 2010-10-14 | — | — | US | disclosed |
| EP-2221293-A1 | AMIDE COMPOUND AND BACTERIAL DISEASE CONTROL AGENT FOR AGRICULTURAL AND HORTICULTURAL USE | The University of Tokyo (JP) | 2010-08-25 | — | — | EP | disclosed |
| US-7482362-B2 | Substituted-4-quinolones | THE SECRETARY OF STATE FOR DEFENSE (GB) | 2009-01-27 | — | — | US | disclosed |
| US-7371779-B2 | Synergistic compositions of N-acylhomoserine lactones and 4-quinolones | THE SECRETARY OF STATE FOR DEFENSE SCIENCE AND TECHNOLOGY (GB) | 2008-05-13 | — | — | US | disclosed |
| EP-1349550-B1 | SUBSTITUTED-4-QUINOLONES FOR THE TREATMENT OF AUTOIMMUNE DISEASES | SECR DEFENCE (GB) | 2006-06-14 | — | — | EP | disclosed |
| EP-1404315-B1 | SYNERGISTIC COMPOSITIONS OF N-ACYLHOMOSERINE LACTONES AND 4-QUINOLONES | UNIV NOTTINGHAM (GB) | 2004-11-03 | — | — | EP | disclosed |
| US-20040198978-A1 | Synergistic compositions of n-acylhomoserine lactones and 4-quinolones | THE SECRETARY OF STATE FOR DEFENCE (GB) | 2004-10-07 | — | — | US | disclosed |
| US-20040082579-A1 | Immunosuppressant | THE SECRETARY OF STATE FOR DEFENCE (GB) | 2004-04-29 | — | — | US | disclosed |
| EP-1404315-A1 | SYNERGISTIC COMPOSITIONS OF N-ACYLHOMOSERINE LACTONES AND 4-QUINOLONES | THE UNIVERSITY OF NOTTINGHAM (GB) | 2004-04-07 | — | — | EP | disclosed |
| EP-1349550-A1 | SUBSTITUTED-4-QUINOLONES | THE UNIVERSITY OF NOTTINGHAM (GB) | 2003-10-08 | — | — | EP | disclosed |
| WO-2003004017-A1 | SYNERGISTIC COMPOSITIONS OF N-ACYLHOMOSERINE LACTONES AND 4-QUINOLONES | THE UNIVERSITY OF NOTTINGHAM (GB) | 2003-01-16 | — | — | WO | disclosed |
| WO-2002047686-A1 | SUBSTITUTED-4-QUINOLONES | THE UNIVERSITY OF NOTTINGHAM (GB) | 2002-06-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100261920-A1 | AMIDE COMPOUND AND BACTERIAL DISEASE CONTROL AGENT FOR AGRICULTURAL AND HORTICULTURAL USE | BROX, NAAA, H1-2 | PTPN1 2881/4885CDC25B 1477/4885ACP1 2967/4885 |
| US-20150366851-A1 | OSTEOPONTIN PRODUCTION INHIBITOR CONTAINING DICTYOPYRONE DERIVATIVE OR DIHYDRODICTYOPYRONE DERIVATIVE AS ACTIVE INGREDIENT | SPPL2B, DPYSL3, DIAPH1 | PTPN1 1624/4885CDC25B 382/4885ACP1 142/4885 |
| US-20040082579-A1 | Immunosuppressant | CCR6, CCR1, CCR8 | PTPN1 263/4885CDC25B 4049/4885ACP1 2437/4885 |
| US-20040198978-A1 | Synergistic compositions of n-acylhomoserine lactones and 4-quinolones | CBR3, CBR1, CNR1 | PTPN1 194/4885CDC25B 2142/4885ACP1 1323/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.